Stock KYMR KYMERA THERAPEUTICS, INC.
Add to a list

Sector valuations Kymera Therapeutics, Inc.

Equities

KYMR

US5015751044

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/04/2026 BST 		5-day change 1st Jan Change
85.05 USD -2.63% Intraday chart for Kymera Therapeutics, Inc. -0.41% +9.30%
04-09 Kymera to Receive $45 Million Milestone Payment as Gilead Exercises Option to License KT-200 MT
04-09 Kymera Therapeutics announces Gilead Sciences' option exercise to license KT-200, oral CDK2 molecular glue degrader development candidate RE
Main competitors
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
KYMERA THERAPEUTICS, INC. Stock Kymera Therapeutics, Inc.
-22.76x6.29x-18.21x144.95x-16.19x-14.63x-.--% 6.94B
LONZA GROUP AG Stock Lonza Group AG
31.36x3.65x1.45x5.5x16.96x23.9x1.05% 45.62B
BEONE MEDICINES AG Stock BeOne Medicines AG
55.97x7.2x0.47x4.84x32.49x40.97x-.--% 34.34B
CELLTRION, INC. Stock Celltrion, Inc.
33.29x2.42x1.16x8.54x21.97x26.44x0.37% 29.46B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
20.7x3.72x6.62x2.38x10.27x15.65x-.--% 28.09B
REVOLUTION MEDICINES, INC. Stock Revolution Medicines, Inc.
-12.57x17.05x-0.43x326.75x-10.64x-10.55x-.--% 19.11B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
49.09x164.39x-0.23x8.71x27.18x37.46x-.--% 14.78B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
28.84x14.69x2.4x4.66x21.22x22.22x-.--% 14.09B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
21.62x2.36x0.65x1.91x8.39x13.09x1.17% 13.25B
IONIS PHARMACEUTICALS, INC. Stock Ionis Pharmaceuticals, Inc.
-18.38x-51.14x-0.26x14.53x-20.1x-18.69x-.--% 12.42B
ABIVAX Stock Abivax
-30.23x39.89x1.16x3097.13x-33.94x-30.33x-.--% 10.03B
PRAXIS PRECISION MEDICINES, INC. Stock Praxis Precision Medicines, Inc.
-21.1x7.83x-1.9x1285.06x-17.65x-17.45x-.--% 8.8B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
44.2x4.01x0.26x7.07x19.78x21.75x0.58% 8.69B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
25.51x2.44x-0.08x2.71x10.62x13.53x-.--% 8.65B
QIAGEN N.V. Stock Qiagen N.V.
18.45x2.23x1.3x4.08x10.98x13.83x0.33% 8.46B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
16.56x0.88x-0.51x1.37x7.01x7.75x-.--% 8.16B
TEMPUS AI, INC. Stock Tempus AI, Inc.
-26.86x18.13x-2.01x5.23x128.84x-252.61x-.--% 7.7B
PHARMARON BEIJING CO., LTD. Stock Pharmaron Beijing Co., Ltd.
27.25x3.22x1.27x3.39x13.99x20.45x0.82% 7.68B
HANGZHOU TIGERMED CONSULTING CO., LTD Stock Hangzhou Tigermed Consulting Co., Ltd
46.72x2.21x2.45x6.02x33.56x44.04x0.37% 6.88B
Average 15.14x 13.24x -0.23x 259.73x 13.93x -2.27x 0.25% 15.43B
Weighted average by Cap. 21.96x 12.70x 0.74x 173.98x 14.73x 9.43x 0.31%
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. KYMR Stock
  4. Sector Kymera Therapeutics, Inc.
  5. Sector valuations

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition